摘要
Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system and society. The aim of this research is to estimate the cost of mild, moderate and severe CSU in Turkey and to forecast the cost of the disease from the payer (Social Security Institution—SSI) perspective. Expert opinions with Delphi technique were used in order to determine the cost items and their frequency. A questionnaire was designed to outline resources used in the out-patient, inpatient and emergency care episodes and was answered by dermatologists followed by a consensus meeting. Unit costs were calculated from the price list of the SSI. The annual total cost of treating the disease to the SSI was estimated as 262,111,978TL (94,417,870€) comprising 0.06% of the total healthcare budget in 2013. Since there is limited information about the cost of CSU in Turkey, the methodology and results of this study are unique and very important.
Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system and society. The aim of this research is to estimate the cost of mild, moderate and severe CSU in Turkey and to forecast the cost of the disease from the payer (Social Security Institution—SSI) perspective. Expert opinions with Delphi technique were used in order to determine the cost items and their frequency. A questionnaire was designed to outline resources used in the out-patient, inpatient and emergency care episodes and was answered by dermatologists followed by a consensus meeting. Unit costs were calculated from the price list of the SSI. The annual total cost of treating the disease to the SSI was estimated as 262,111,978TL (94,417,870€) comprising 0.06% of the total healthcare budget in 2013. Since there is limited information about the cost of CSU in Turkey, the methodology and results of this study are unique and very important.
作者
Mehtap Tatar
Ayşen Şentürk
Gülpembe Ergin Oğuzhan
Esin Tuna
Cem Mat
Emel Bülbül Başkan
Ferda Artüz
Mehmet Ali Gürer
Nilgün Atakan
Serhat İnalöz
Selin Sezen Çavuşoğlu
Abdülkadir Keskinaslan
İsmail Mete Şaylan
Mehtap Tatar;Ayşen Şentürk;Gülpembe Ergin Oğuzhan;Esin Tuna;Cem Mat;Emel Bülbül Başkan;Ferda Artüz;Mehmet Ali Gürer;Nilgün Atakan;Serhat İnalöz;Selin Sezen Çavuşoğlu;Abdülkadir Keskinaslan;İsmail Mete Şaylan(Department of Health Care Management, Faculty of Economics and Administrative Sciences, Hacettepe University, Ankara, Turkey;Polar Health Economics and Policy Consultancy, Ankara, Turkey;Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey;Uludag University Faculty of Medicine, Bursa, Turkey;Ankara Numune Training and Research Hospital, Ankara, Turkey;Gazi University Faculty of Medicine, Ankara, Turkey;Hacettepe University Faculty of Medicine, Ankara, Turkey;Gaziantep University Faculty of Medicine, Gaziantep, Turkey;Novartis, Suryapi & Akel is Merkezi, istanbul, Turkey)
出处
《Health》
CAS
2016年第11期1098-1103,共7页
健康(英文)